Roni Moya
CESPU University, Portugal
Title: Immune modulation with xenogeneic peptides in integrative oncology
Biography
Biography: Roni Moya
Abstract
Cell therapy with extracts of xenogeneic peptides consists of administering intramuscularly, intravenous, subcutaneous or orally, frozen tissue extracts from sheep, cow or pig in order to modulate the immune system and activate the biological signs of organic regeneration. It is a State-of-the-art treatment in the area of regenerative medicine and immunology demonstrated for the first time in 1912 by Nobel Prize winner Alexis Carrel in the rejuvenation of in vitro aged cells. In 1931, it was applied in humans with great success by Dr Paul Niehens. One of the main areas where the xenogeneic cellular therapy peptides can be applied is Oncology. Purified animal extracts work on innate or acquired immunity by the stimulation of fundamental organs as the thymus, spleen and bone marrow by regulating the transcription, apoptosis, oxidative stress, the activation of B lymphocytes, CD4, CD8, and Natural Killer (NK); as well as the production of its main cytokines (IFN, TNF, IL4, Order, etc). The main purpose of this conference is to addressing the clinical aspects and the most relevant scientific studies of integrative treatment with xenogeneic peptides as a potent immune-modulator in cancer cases.